Role of CYP2C19 pharmacogenetic polymorphism on response of esomeprazole in the treatment of GERD

被引：0
作者：
Halimi, Shafarul
Abu Hassan, Muhammad Radzi
Ismail, Rusli
Kiew, Kuang Kiat
Zainuddin, Zalwani
Mustapha, Mohd Nazri
Mokhtar, Suraya
机构：
[1] Univ Sains Malaysia, George Town, Malaysia
[2] Hosp Univ Sains Malaysia, George Town, Malaysia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
pharmacogenetics; polymorphism; GERD;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [41] Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice
    Russmann, Stefan
    Rahmany, Ali
    Niedrig, David
    Hatz, Karl-Dietrich
    Ludin, Katja
    Burden, Andrea M.
    Englberger, Lars
    Backhaus, Roland
    Serra, Andreas
    Bechir, Markus
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 709 - 716
  • [42] Analysis of CYP2C19 Genetic Polymorphism in a Large Ethnic Hakka Population in Southern China
    Zhong, Zhixiong
    Hou, Jingyuan
    Li, Bing
    Zhang, Qifeng
    Liu, Sudong
    Li, Cunren
    Liu, Zhidong
    Yang, Min
    Zhong, Wei
    Zhao, Pingsen
    MEDICAL SCIENCE MONITOR, 2017, 23 : 6186 - 6192
  • [43] Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population
    Halling, J
    Petersen, M
    Damkier, P
    Nielsen, F
    Grandjean, P
    Weihe, P
    Lundgren, S
    Lundblad, M
    Brosen, K
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 491 - 497
  • [44] CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients
    Yang Jie
    Zhao Hong-Dong
    Tan Jie
    Ding Yun-Long
    Zou Jian-Jun
    PHARMAZIE, 2013, 68 (03): : 183 - 186
  • [45] CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs
    Sienkiewicz-Oleszkiewicz, B.
    Wiela-Hojenska, A.
    PHARMAZIE, 2018, 73 (11): : 619 - 624
  • [46] Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Rosuvastatin in Healthy Taiwanese Subjects
    Finkelman, Richard D.
    Wang, Tzung-Dau
    Wang, Yi
    Azumaya, Connie T.
    Birmingham, Bruce K.
    Wissmar, Jenny
    Mosqueda-Garcia, Rogelio
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (01): : 33 - 40
  • [47] Clinical implications of CYP2C19 polymorphism for tailor-made pharmacotherapy
    Sohn, DR
    PHARMACOGENETICS - TAILOR-MADE PHARMACOTHERAPY, 2002, 1244 : 41 - 49
  • [48] Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite
    Damle, Bharat D.
    Uderman, Howard
    Biswas, Pinaki
    Crownover, Penelope
    Lin, Chang
    Glue, Paul
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (05) : 682 - 689
  • [49] Analysis of the CYP2C19 polymorphism in a North-eastern Thai population
    Tassaneeyakul, W
    Tawalee, A
    Tassaneeyakul, W
    Kukongviriyapan, V
    Blaisdell, J
    Goldstein, JA
    Gaysornsiri, D
    PHARMACOGENETICS, 2002, 12 (03): : 221 - 225
  • [50] Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions
    Fohner, Alison E.
    Rettie, Allan E.
    Thai, Khanh K.
    Ranatunga, Dilrini K.
    Lawson, Brian L.
    Liu, Vincent X.
    Schaefer, Catherine A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (05): : 1004 - 1009
12345